1,579 Followers on Owler
OverviewCompetitorsFundingInvestmentsNews & Insights

Allogene Competitors or Alternatives

Allogene's top competitors include Cellectis, Mustang Bio and bluebird bio.

Unlock 14 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Allogene's company profile

David Chang

President & CEO

65/100
310
$834.8M
$ < 1M
  • $834.8M
    $ < 1M
  • 310
    $834.8M
  • $ < 1M
  • 65/100
  • 310
  • $834.8M
  • $ < 1M
View ProfileView
1
Allogene's Competitor - Cellectis logo

Andre Choulika

CEO

89/100
221
$1B
$12.1M
  • $1B
    $12.1M
  • 221
    $1B
  • $12.1M
  • 89/100
  • 221
  • $1B
  • $12.1M
View ProfileView
2
Allogene's Competitor - Mustang Bio logo

Manuel Litchman

President & CEO

90/100
100
$354.3M
$2.4M
  • $354.3M
    $2.4M
  • 100
    $354.3M
  • $2.4M
  • 90/100
  • 100
  • $354.3M
  • $2.4M
View ProfileView
3
Allogene's Competitor - bluebird bio logo

Andrew Obenshain

CEO

73/100
520
$821.4M
$83.8M
  • $821.4M
    $83.8M
  • 520
    $821.4M
  • $83.8M
  • 73/100
  • 520
  • $821.4M
  • $83.8M
View ProfileView
4
Allogene's Competitor - Poseida logo

Kristin Yarema

President & CEO

85/100
260
$691M
$150.9M
  • $691M
    $150.9M
  • 260
    $691M
  • $150.9M
  • 85/100
  • 260
  • $691M
  • $150.9M
View ProfileView
5
Allogene's Competitor - Atara logo

Pascal Touchon

President & CEO

90/100
330
$107M
$128.9M
  • $107M
    $128.9M
  • 330
    $107M
  • $128.9M
  • 90/100
  • 330
  • $107M
  • $128.9M
View ProfileView
Allogene's top 17 competitors are Cellectis, Mustang Bio, bluebird bio, Novartis, Poseida, Atara, Kite Pharma, CRISPR, Bristol-Myers Squibb, Nexo Therapeutics, Abeona, AstraZeneca, Fate Therapeutics, Bellicum, Juno Therapeutics, Precigen and Johnson & Johnson. Together they have raised over 31.0B between their estimated 358.5K employees. Allogene has 310 employees and is ranked lowest among it's top 10 competitors. The top 10 competitors average 19,931.

Allogene VS Cellectis

Cellectis is one of Allogene's top competitors. Cellectis was founded in 1999, and its headquarters is in Paris, Île-de-France. Like Allogene, Cellectis also works within the Biotechnology sector. Cellectis has 89 fewer employees than Allogene.

Allogene VS Mustang Bio

Mustang Bio is Allogene's #2 rival. Mustang Bio was founded in 2015 in Worcester, New York. Mustang Bio operates in the Biotechnology industry. Mustang Bio generates $2.4M more revenue than Allogene.

Allogene VS bluebird bio

bluebird bio is a top competitor of Allogene. bluebird bio is a Public company that was founded in Somerville, Massachusetts in 1992. bluebird bio is in the Biotechnology field. bluebird bio has 210 more employees vs. Allogene.

Looking for similar companies to Allogene?

Similar Companies

Companies in South San Francisco with employees in 100-250 range

See 124 companies 
Biotechnology companies in South San Francisco

See 150 companies 
Biotechnology companies with employees in 100-250 range

See 1,100 companies 
Pharmaceuticals & Biotechnology companies in South San Francisco

See 173 companies 
Biotechnology companies in San Francisco Bay Area

See 1,319 companies 
Pharmaceuticals & Biotechnology companies in San Francisco Bay Area

See 1,673 companies 
Pharmaceuticals & Biotechnology companies with employees in 100-250 range

See 1,792 companies 
Biotechnology companies in California

See 3,097 companies 
Pharmaceuticals & Biotechnology companies in California

See 4,180 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Allogene and Allogene's Competitors

March 28, 2025Pharmabiz
Novartis will present data from studies across its neuroscience portfolio, including seven─year disability outcomes and safety data from the ALITHIOS o...
March 28, 2025Crain's Newyork Business
Bristol-Myers Squibb awarded its CEO nearly $19 million in compensation for 2024, following a challenging year for the pharmaceutical company.The New J...
March 28, 2025StreetInsider
SOMERVILLE, Mass.--(BUSINESS WIRE)-- bluebird bio, Inc. (NASDAQ: BLUE) (bluebird) today confirmed it has received an unsolicited non-binding written pr...
March 28, 2025Openpr
Pulmonary Drug Delivery Systems Market is estimated to be valued at USD 37.57 Bn in 2025 and is expected to reach USD 51.47 Bn in 2032, exhibiting a co...
March 28, 2025Benzinga
The U.S. Food and Drug Administration (FDA) on Friday approved Novartis AG's (NYSE:NVS) Pluvicto for prostate cancer patients.The expanded indication, ...
March 28, 2025FinanzNachrichten
Recommendation based on Phase 3 CheckMate -77T trial showing significant event-free survival improvement when compared to neoadjuvant chemotherapy and ...
March 28, 2025The Business Journals: Boston
The Somerville gene therapy company has found itself in a bidding war, and a deal that seemed settled is now back up in the air....
March 28, 2025Thetidewaternews
FDA approves Novartis radioligand therapy Pluvicto® for earlier use before chemotherapy in PSMA-positive metastatic castration-resistant prostate cance...
March 29, 2025Drugs
All News Consumer Pro New Drugs Pipeline Clinical Trials FDA Alerts Basel, March 28, 2025 - Novartis announced today that the US Food and Drug Administ...
March 28, 2025Owler
bluebird bio’s Trailing Twelve Months revenue changed from $53.12M in Sep 2024 to $83.81M in Dec 2024 increasing 57.8% in this time period....

Frequently Asked Questions about Allogene

  1. Who are Allogene's top competitors?

    Allogene's top 3 competitors are Cellectis, Mustang Bio, bluebird bio.

  2. Who is similar to Allogene?

    Cellectis is the most similar to Allogene. Mustang Bio and bluebird bio are also similar to Allogene.

  1. Are Allogene and Cellectis competitors?

    Yes, Cellectis is one of Allogene’s top competitors.